Adult Pleomorphic Rhabdomyosarcomas: Assessing Outcomes Associated with Radiotherapy and Chemotherapy Use in the National Cancer Database
Table 2
Baseline patient characteristics.
Total
%
Total, n
243
100
Surgery type
Resection or LSS∗
225
93
Amputation
18
7
Receipt of radiotherapyϕ
No
102
42
Yes
141
58
Receipt of chemotherapy
No
135
56
Yes
108
44
Age
<70 years
158
65
≥70 years
85
35
Gender
Male
151
62
Female
92
38
Race
Non-Hispanic White
191
79
Non-Hispanic Black
20
8
Hispanic
18
7
Other
14
6
Facility area
Metropolitan
202
83
Urban
26
11
Rural
8
3
Unknown
7
3
Insurance
Commercial
113
47
Medicare
102
42
Medicaid
17
7
Uninsured
3
1
Other
8
3
Zip code education level
≥21%
40
16
13%–20.9%
59
24
7%–12.9%
77
32
<7%
67
28
Zip code income level
<38,000
41
17
38,000–47,999
53
22
48,000–62,999
74
30
≥63,000
75
31
Facility type
Non-academic
103
42
Academic
114
47
Unknown
26
11
Facility location
East
45
19
South
68
28
Central
53
22
West
51
21
Unknown
26
11
Distance to treatment facility
≤40 miles
171
70
>40 miles
72
30
Charlson/Deyo score
0
196
81
1
36
15
2
7
3
3
4
2
Primary site
Head and neck
12
5
Upper extremity
40
16
Lower extremity
120
49
Thorax
23
9
Abdomen/pelvis
46
19
Other/NOS
2
1
Grade
II
11
5
III
232
95
Tumor size
<5 cm
51
21
5.1–10 cm
102
42
10.1–15 cm
52
21
>15 cm
38
16
Clinical stage
II
51
21
III
192
79
Year of diagnosis
2004–2007
74
30
2008–2011
78
32
2012–2015
91
37
∗Limb-sparing surgery. ϕWhen considering only those patients who did not undergo amputation, for whom RT would not be indicated, 86 (38%) did not receive radiotherapy and 139 (62%) received radiotherapy.
